Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Arrayit Corporation (ARYC) Message Board

SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayi

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 170
Posted On: 05/13/2015 12:33:25 PM
Posted By: hotforpenny
SUNNYVALE, CA / ACCESSWIRE / May 13, 2015 / Arrayit Corporation (OTCQB: ARYC) a life science technology leader, announces an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth.

Vivos offers an impervious, impenetrable and permanent DNA storage vault, able to provide virtually every man, woman and child on Earth, a safe and secure, nuclear blast-proof, underground shelter to store their DNA. It is predicted in the near future that your own DNA will be used to extend your life. Healthy DNA will be used as a means of regenerative medicine, to restore normal healthy function to body organs, skin tissue, and parts damaged by disease, injured by trauma, or just worn out by time. Storing a small sample of your DNA as it exists today may assure a longer life through cures and the restoration of virtually every cell in your body. Arrayit blood cards allow the rapid collection, separation, drying and storage of human genomic DNA in a format that is permanent and highly miniaturized.

Arrayit CEO Rene Schena states, "We are pleased to partner with Vivos on this ambitious scientific project. Rapid advances in biomedical research offer the promise of future scientific breakthroughs based on high quality archival genomic DNA."

Vivos CEO and founder Robert Vicino adds, "Arrayit technology will play an instrumental role in safely and confidentially storing private customer DNA samples in the Global Genome Vault. Preserving your DNA for posterity provides the personal blueprint required to leverage scientific advances including possible medical regeneration and life extension in the future."


(0)
(0)




Arrayit Corporation (ARYC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us